Our data support a critical role of the p21 CDK inhibitor, a p53 target, in these actions since p21-deleted p53wt cells exhibited a response similar to p53mt cancer cells, demonstrated by the γH2AX data in response to deoxyuridine analogues. This evidence concerns the gene CDKN1A and cancer.